CL vs KVUE
CL: Global leader in oral care, personal care, home care, and premium pet nutrition with iconic brands sold in over 200 countries. KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories.
Side-by-side fundamentals
| Metric | CL | KVUE | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $91.01 | $19.18 | |
| Market cap as of 2026-07-10 | $73.5B | $36.8B | |
| P/E as of 2026-07-10 | 35.21 | 22.70 | KVUE lower |
| PEG as of 2026-07-10 | 7.23 | 2.72 | KVUE lower |
| Net margin as of 2026-07-10 | +10.0% | +10.6% | KVUE higher |
| Gross margin as of 2026-07-10 | +60.1% | +58.9% | CL higher |
| Operating margin as of 2026-07-10 | +15.4% | +17.1% | KVUE higher |
| ROE as of 2026-07-10 | +475.1% | +15.2% | CL higher |
| ROA as of 2026-07-10 | +12.3% | +6.0% | CL higher |
| Debt / equity as of 2026-07-10 | 54.99 | 0.82 | KVUE lower |
| Revenue growth (YoY) as of 2026-07-10 | +4.3% | -0.1% | CL higher |
| Revenue CAGR (3y) SEC XBRL | +4.3% | +0.2% | CL higher |
| Dividend yield as of 2026-07-10 | +2.3% | +4.3% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 1 | 3 | KVUE higher |
| Beta as of 2026-07-10 | 0.33 | 0.45 | |
| 1-year return as of 2026-07-09 close | -0.6% | -6.8% | CL higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.